HUP0202645A3 - Fornulations for parenteral use of estramustine phosphate and albumin - Google Patents
Fornulations for parenteral use of estramustine phosphate and albuminInfo
- Publication number
- HUP0202645A3 HUP0202645A3 HU0202645A HUP0202645A HUP0202645A3 HU P0202645 A3 HUP0202645 A3 HU P0202645A3 HU 0202645 A HU0202645 A HU 0202645A HU P0202645 A HUP0202645 A HU P0202645A HU P0202645 A3 HUP0202645 A3 HU P0202645A3
- Authority
- HU
- Hungary
- Prior art keywords
- fornulations
- albumin
- parenteral use
- estramustine phosphate
- estramustine
- Prior art date
Links
- 102000009027 Albumins Human genes 0.000 title 1
- 108010088751 Albumins Proteins 0.000 title 1
- 229960004750 estramustine phosphate Drugs 0.000 title 1
- ADFOJJHRTBFFOF-RBRWEJTLSA-N estramustine phosphate Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)OP(O)(O)=O)[C@@H]4[C@@H]3CCC2=C1 ADFOJJHRTBFFOF-RBRWEJTLSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9918779.1A GB9918779D0 (en) | 1999-08-09 | 1999-08-09 | Formulations for parenteral use of estramustine phosphate and albumin |
IT1999MI001998 IT1313629B1 (it) | 1999-09-27 | 1999-09-27 | Formulazioni di estramustina fosfato ed albumina per uso parenterale |
PCT/EP2000/007678 WO2001010446A2 (en) | 1999-08-09 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate and albumin |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0202645A2 HUP0202645A2 (hu) | 2002-12-28 |
HUP0202645A3 true HUP0202645A3 (en) | 2004-06-28 |
Family
ID=26315835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0202645A HUP0202645A3 (en) | 1999-08-09 | 2000-08-03 | Fornulations for parenteral use of estramustine phosphate and albumin |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1206266A2 (es) |
JP (1) | JP2003506408A (es) |
KR (1) | KR20020019967A (es) |
CN (1) | CN1511037A (es) |
AU (1) | AU6280900A (es) |
BR (1) | BR0013276A (es) |
CA (1) | CA2380312A1 (es) |
CZ (1) | CZ2002376A3 (es) |
EA (1) | EA200200234A1 (es) |
HU (1) | HUP0202645A3 (es) |
IL (1) | IL147745A0 (es) |
MX (1) | MXPA02001395A (es) |
NO (1) | NO20020631D0 (es) |
NZ (1) | NZ517632A (es) |
PL (1) | PL353406A1 (es) |
SK (1) | SK1782002A3 (es) |
WO (1) | WO2001010446A2 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100426450B1 (ko) * | 2002-03-16 | 2004-04-13 | 박래옥 | 구연산, 알부민 및 아연을 함유한 항암 조성물 |
ES2685436T3 (es) * | 2002-12-09 | 2018-10-09 | Abraxis Bioscience, Llc | Composiciones y procedimientos para administración de agentes farmacológicos |
ZA200409537B (en) | 2003-01-31 | 2006-10-25 | Yamanouchi Pharma Co Ltd | Stable solid medicinal composition for oral administration |
KR101198346B1 (ko) | 2003-04-08 | 2012-11-06 | 노보 노르디스크 에이/에스 | 크로마토그래피 고정상의 재생 |
WO2004089985A1 (en) | 2003-04-11 | 2004-10-21 | Novo Nordisk A/S | Stable pharmaceutical compositions |
DE102006024528A1 (de) * | 2006-05-23 | 2007-11-29 | Albupharm Heidelberg Gmbh & Co. Kg | Neue, an der Tumorphysiologie orientierte Formulierung eines Zytostatikums, insbesondere von cis-Platin |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59108800A (ja) * | 1982-12-13 | 1984-06-23 | Japan Atom Energy Res Inst | 誘導ミサイル作用および制癌剤の徐放性機能をもつ微粒子 |
US20020039594A1 (en) * | 1997-05-13 | 2002-04-04 | Evan C. Unger | Solid porous matrices and methods of making and using the same |
-
2000
- 2000-08-03 EP EP00949471A patent/EP1206266A2/en not_active Withdrawn
- 2000-08-03 CA CA002380312A patent/CA2380312A1/en not_active Abandoned
- 2000-08-03 IL IL14774500A patent/IL147745A0/xx unknown
- 2000-08-03 JP JP2001514963A patent/JP2003506408A/ja not_active Withdrawn
- 2000-08-03 PL PL00353406A patent/PL353406A1/xx not_active Application Discontinuation
- 2000-08-03 CN CNA008114420A patent/CN1511037A/zh active Pending
- 2000-08-03 WO PCT/EP2000/007678 patent/WO2001010446A2/en not_active Application Discontinuation
- 2000-08-03 HU HU0202645A patent/HUP0202645A3/hu unknown
- 2000-08-03 CZ CZ2002376A patent/CZ2002376A3/cs unknown
- 2000-08-03 NZ NZ517632A patent/NZ517632A/en unknown
- 2000-08-03 SK SK178-2002A patent/SK1782002A3/sk unknown
- 2000-08-03 MX MXPA02001395A patent/MXPA02001395A/es unknown
- 2000-08-03 EA EA200200234A patent/EA200200234A1/ru unknown
- 2000-08-03 AU AU62809/00A patent/AU6280900A/en not_active Abandoned
- 2000-08-03 BR BR0013276-4A patent/BR0013276A/pt not_active IP Right Cessation
- 2000-08-03 KR KR1020027001700A patent/KR20020019967A/ko not_active Application Discontinuation
-
2002
- 2002-02-08 NO NO20020631A patent/NO20020631D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2001010446A3 (en) | 2001-05-25 |
IL147745A0 (en) | 2002-08-14 |
NO20020631L (no) | 2002-02-08 |
SK1782002A3 (en) | 2002-05-09 |
CA2380312A1 (en) | 2001-02-15 |
EA200200234A1 (ru) | 2002-06-27 |
CZ2002376A3 (cs) | 2002-06-12 |
MXPA02001395A (es) | 2002-08-12 |
EP1206266A2 (en) | 2002-05-22 |
NO20020631D0 (no) | 2002-02-08 |
JP2003506408A (ja) | 2003-02-18 |
PL353406A1 (en) | 2003-11-17 |
KR20020019967A (ko) | 2002-03-13 |
BR0013276A (pt) | 2004-08-03 |
WO2001010446A2 (en) | 2001-02-15 |
AU6280900A (en) | 2001-03-05 |
HUP0202645A2 (hu) | 2002-12-28 |
CN1511037A (zh) | 2004-07-07 |
NZ517632A (en) | 2004-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL366205A1 (en) | Methods and systems for finding value and reducing risk | |
HUP0202477A3 (en) | Use of phthalazine derivatives | |
ZA988937B (en) | Benzamidine derivatives Benzamidine derivatives | |
HUP0200898A2 (en) | Derivatives of venlafaxine and methods of preparing and using the same | |
IL146094A0 (en) | Diaminothiazoles and their use for inhibiting protein kinases | |
PL341008A1 (en) | Benzamidine derivatives | |
EP1208475A4 (en) | SYSTEM FOR MAINTAINING PRECOMPUTTERED VIEWS | |
AU1111300A (en) | Automatically identifiable and trackable article and system interacting with same | |
TW427126U (en) | Connection structure for fixture and containing article | |
EP1198184A4 (en) | TRANSFER METHOD AND ARTICLE | |
GB2367103B (en) | Connector and method of use of the connector | |
GB2352523B (en) | Fluid-gauging systems and methods | |
GB0023323D0 (en) | Arylhydantoin derivatives and uses thereof | |
AU7271600A (en) | Quinazolinone and azaquinazolinone derivatives | |
HUP0202729A3 (en) | Compositions for parenteral use of estramustine phosphate and amino acids | |
EP1194147A4 (en) | DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE | |
HUP0202645A3 (en) | Fornulations for parenteral use of estramustine phosphate and albumin | |
GB9921958D0 (en) | Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins | |
AU6754800A (en) | Integrated system and method of creating intelligent agents | |
HU0002717D0 (en) | 13-deoxyanthracycline derivatives and processes for preparing them | |
GB9918779D0 (en) | Formulations for parenteral use of estramustine phosphate and albumin | |
GB0021915D0 (en) | Creating and managing E-receipts | |
HUP0201610A2 (en) | Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin | |
IL133612A0 (en) | Formulations containing estramustine phosphate and albumin | |
AU6230499A (en) | Method for preparing 2-chloropropionaldehyde and use of the same |